Lupin Launches Its Oral Contraceptive Daysee Tablets in the U.S. Market; Generic of Seasonique Tablets

Pharma major Lupin announced that its subsidiary Lupin Pharmaceuticals has received final approval for its Daysee tablets from the FDA to market a generic version of Teva’s Seasonique.
International Business Times